LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Immuno-Oncology Therapy for Hepatocellular Carcinoma: Current Status and Ongoing Trials

Photo from wikipedia

The major histocompatibility complex on antigen-presenting cells recognizes tumorassociated antigens on the surface of cancer cells and presents the antigen to T-cell receptors on immature T cells upon migration of… Click to show full abstract

The major histocompatibility complex on antigen-presenting cells recognizes tumorassociated antigens on the surface of cancer cells and presents the antigen to T-cell receptors on immature T cells upon migration of antigen-presenting cells to the lymph nodes. Immature T cells are not activated by antigen stimulation (first signal) alone, but also require an activating costimulatory signal (second signal). The second signal is provided by the binding of Received: June 14, 2019 Accepted: June 14, 2019 Published online: July 9, 2019

Keywords: hepatocellular carcinoma; oncology therapy; therapy hepatocellular; immuno oncology; antigen; oncology

Journal Title: Liver Cancer
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.